SleepBrag Twitter Community Guidelines

Welcome to the SleepBrag Twitter channel!

This channel was created and is managed by Pernix Therapeutics. It aims to educate people about the value of sleep and share tips to aid in people’ sleep routine. The content posted by @SleepBrag is for informational purposes only and is NOT intended to be a substitute for professional medical advice.


We are looking forward to hearing from you via re-tweets, Favorites, @mentions and replies. However, please note, the pharmaceutical industry is a highly regulated one and as a result we are not allowed to engage in sensitive topics, or discussion(s) about products on our Twitter channels.

We may not be able to respond to @mentions and replies that:

  1. Mention any product
  2. Include profanity, defamatory, libelous, offensive, abusive, discriminatory or demeaning content (including images, videos and links)
  3. Are disparaging, threatening, condone violence or illegal behavior
  4. Offer health or medical advice
  5. Are commercial or advertising, e.g. sell products and services, or recruit fans and followers
  6. Are spam
  7. Are excessively repetitive and/or disruptive to the community
  8. Are questions directly related to financial, legal, regulatory, confidential information or medical issues
  9. Violate Twitter’s Platform Rules

Language Considerations

Our Twitter feeds are English speaking only. Non-English tweets may not be responded to.


Twitter accounts that @SleepBrag follows or is followed by are not an indication of Pernix’s endorsement of these accounts or the content they produce. Additionally, Favorites and/or Re-tweets also may not indicate endorsement.

Medical side effects or adverse events

Please do not use this channel to report adverse events. However, if you believe that you have experienced any medical side effects or reactions from a Pernix product you should consult your physician, pharmacist or other healthcare professional immediately. You can also report these to us directly here: Phone: (800) 793-2145 or Email: drugsafety@pernixtx.com.